Filter
1074
Text search:
submission
Featured
79
318
Language
Document type
597
187
150
55
41
18
11
8
4
2
1
Countries / Regions
91
50
35
33
28
28
27
25
24
23
22
21
19
18
17
17
17
16
16
15
14
13
12
9
9
9
9
9
8
8
8
7
7
6
6
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
527
58
43
38
36
16
16
Toolboxes
82
60
55
49
47
41
33
29
28
26
26
24
23
19
17
14
13
11
10
9
7
5
3
2
a landscape report of voluntary medical male circumcision priority countries.
This report provides the findings from the baseline implementation of these tools in 15 VMMC priority countries in 2021. It is intended for VMMC national programme leaders and implementing and global partners. Its goals a
...
In response to the growing necessity for accurate and timely information regarding deaths categorized by age, sex, and cause of death, underscored by the profound impact of the COVID-19 pandemic, the Africa Centres for Disease Control and Prevention (Africa CDC) developed the Continental Framework d
...
HIV rapid diagnostic test market landscape
recommended
The analysis includes the three most commonly used HIV rapid diagnostic test
(RDT) categories: HIV-only professional use RDTs, dual HIV/syphilis professional use
RDTs, and HIV self-tests (HIVST).
This ToR outlines the background, purpose,
audience, and use of the evaluation, objective and key evaluation questions,
methodological considerations, timeline and deliverables, and the technical
requirements the prospective evaluation team should meet
Through the “Fiji National HIV Surge Strategic Plan 2024-2027,” the ministry will address areas for
Prevention, Diagnostics, Treatment and Care, the Continuum of Care and an intense Monitoring,
Evaluation, Accountability and Learning Framework for the government. This strategic plan aims
to d
...
The document Integrated Disease Surveillance and Response Technical Guidelines, Booklet Four: Sections 8 and 9 (Third Edition, 2019) provides guidance for strengthening public health surveillance and response systems in the WHO African Region. It focuses on monitoring, supervision, evaluation, and f
...
This report examines how clinical trials contribute to environmental impacts and outlines key considerations for integrating environmental sustainability into trial design, conduct and oversight. It explores the carbon footprint and resource use associated with clinical research activities – inclu
...
This Mobile user guidance is aimed at supporting implementation of EWARS in a box, WHO’s electronic early warning, alert and response system in emergencies. This guidance fulfills a long felt need to have an easy to use resource with step-by-step instructions in establishing EWARS in a box, facili
...
The document “Interim Guidelines – Infectious Disease Outbreak Response and Analytic System” published by the United Nations provides a framework for how UN missions and organizations should detect, report, analyze, and respond to infectious disease outbreaks. It outlines a coordinated system
...
Female genital mutilation (FGM) is a human rights violation deeply rooted in gender inequality and discrimination. FGM violates various human rights under international human rights law including, among others, the rights to equality, life and health and the rights to be free from discrimination, to
...
The document provides guidance from the CDC on conducting an Operational Readiness Review (ORR) within the Public Health Emergency Preparedness (PHEP) cooperative agreement. It outlines the purpose, structure, and evaluation criteria used to assess whether public health systems are prepared to respo
...
This report presents the performance results of 21 household water treatment (HWT) products evaluated in Rounds III and IV of the WHO International Scheme to Evaluate Household Water Treatment Technologies (the Scheme). Released alongside a consolidated overview of findings from Rounds I–II, it re
...
This chronology of facts has challenged public health systems worldwide and regulatory bodies are no exception. Regulatory authorities with mechanisms in place to authorize the use of investigational products had to development guidelines and procedures, create task forces and alliances to maximize
...
